The level of claudin-7 is reduced as an early event in colorectal carcinogenesis

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Bornholdt, Jette ^a   Friis, Stine ^a   Godiksen, Sine ^b   Poulsen, Steen S ^a   Santoni Rugiu, Eric ^c   Bisgaard, Hanne C ^a   Lothe, Inger M B ^d   Ikdahl, Tone ^d   Tveit, Kjell M ^d   Johnson, Egil ^d,e   Kure, Elin H ^d,f   Vogel, Lotte K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 7; MESSENGER RNA; CLDN7 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; ARTICLE; CANCER PATIENT; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EPITHELIUM DYSPLASIA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; ADENOMA; AGED; BIOLOGICAL MODEL; CARCINOMA; CELL TRANSFORMATION; COLORECTAL TUMOR; DOWN REGULATION; EARLY DIAGNOSIS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED;

ADENOMA; AGED; AGED, 80 AND OVER; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DOWN-REGULATION; EARLY DETECTION OF CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, BIOLOGICAL;

EID: 79751531038     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-65     Document Type: Article

References (41)

1. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999, 20:1425-1431. 10.1093/carcin/20.8.1425, 10426787.
2. Angelow S, Ahlstrom R, Yu AS. Biology of claudins. Am J Physiol Renal Physiol 2008, 295:F867-F876. 10.1152/ajprenal.90264.2008, 2576152, 18480174.
3. Martin TA, Jiang WG. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 2009, 1788:872-891. 10.1016/j.bbamem.2008.11.005, 19059202.
4. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003, 81:1-44. 10.1016/S0079-6107(02)00037-8, 12475568.
5. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001, 2:285-293. 10.1038/35067088, 11283726.
6. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta 2008, 1778:631-645.
7. Ouban A, Ahmed AA. Claudins in human cancer: a review. Histol Histopathol 2010, 25:83-90.
8. Will C, Fromm M, Muller D. Claudin tight junction proteins: novel aspects in paracellular transport. Perit Dial Int 2008, 28:577-584.
9. Oliveira SS, Morgado-Diaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci 2007, 64:17-28. 10.1007/s00018-006-6314-1, 17115119.
10. Hou J, Gomes AS, Paul DL, Goodenough DA. Study of claudin function by RNA interference. J Biol Chem 2006, 281:36117-36123. 10.1074/jbc.M608853200, 17018523.
11. Alexandre MD, Jeansonne BG, Renegar RH, Tatum R, Chen YH. The first extracellular domain of claudin-7 affects paracellular Cl- permeability. Biochem Biophys Res Commun 2007, 357:87-91. 10.1016/j.bbrc.2007.03.078, 17400193.
12. Tatum R, Zhang Y, Salleng K, Lu Z, Lin JJ, Lu Q, et al. Renal salt wasting and chronic dehydration in claudin-7-deficient mice. Am J Physiol Renal Physiol 2010, 298:F24-F34. 10.1152/ajprenal.00450.2009, 2806124, 19759267.
13. Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, Amasheh S, et al. Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 2010, 123:1913-1921. 10.1242/jcs.060665, 20460438.
14. List K, Szabo R, Molinolo A, Nielsen BS, Bugge TH. Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. American Journal of Pathology 2006, 168:1513-1525. 10.2353/ajpath.2006.051071, 1606590, 16651618.
15. List K, Szabo R, Molinolo A, Sriuranpong V, Redeye V, Murdock T, et al. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev 2005, 19:1934-1950. 10.1101/gad.1300705, 1186192, 16103220.
16. Szabo R, Hobson JP, Christoph K, Kosa P, List K, Bugge TH. Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice. Development 2009, 136:2653-2663. 10.1242/dev.038430, 2709071, 19592578.
17. Szabo R, Molinolo A, List K, Bugge TH. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 2007, 26:1546-1556. 10.1038/sj.onc.1209966, 16983341.
18. List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, Swaim W, et al. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development and thymic homeostasis. Oncogene 2002, 21:3765-3779. 10.1038/sj.onc.1205502, 12032844.
19. List K, Kosa P, Szabo R, Bey AL, Wang CB, Molinolo A, et al. Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway. Am J Pathol 2009, 175:1453-1463. 10.2353/ajpath.2009.090240, 2751542, 19717635.
20. Buzza MS, Netzel-Arnett S, Shea-Donohue T, Zhao A, Lin CY, List K, et al. Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci USA 2010, 107:4200-4205. 10.1073/pnas.0903923107, 2840089, 20142489.
21. Vogel LK, Saebo M, Skjelbred CF, Abell K, Pedersen ED, Vogel U, et al. The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. BMC Cancer 2006, 6:176. 10.1186/1471-2407-6-176, 1525198, 16820046.
22. Selzer-Plon J, Bornholdt J, Friis S, Bisgaard HC, Lothe IM, Tveit KM, et al. Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer 2009, 9:201. 10.1186/1471-2407-9-201, 2717118, 19555470.
23. Coyne CB, Gambling TM, Boucher RC, Carson JL, Johnson LG. Role of claudin interactions in airway tight junctional permeability. Am J Physiol Lung Cell Mol Physiol 2003, 285:L1166-L1178.
24. Nakayama F, Semba S, Usami Y, Chiba H, Sawada N, Yokozaki H. Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma. Pathobiology 2008, 75:177-185. 10.1159/000124978, 18550915.
25. Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, Klingbeil P, et al. A complex of EpCAM, claudin-7, CD44 variant isoforms and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 2007, 5:553-567. 10.1158/1541-7786.MCR-06-0384, 17579117.
26. Obayashi T, Hayashi S, Shibaoka M, Saeki M, Ohta H, Kinoshita K. COXPRESdb: a database of coexpressed gene networks in mammals. Nucleic Acids Res 2008, 36:D77-D82. 10.1093/nar/gkm840, 2238883, 17932064.
27. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003, 38:635-642. 10.1080/00365520310003002, 12825872.
28. Johnson MR, Wang KS, Smith JB, Heslin MJ, Diasio RB. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Analytical Biochemistry 2000, 278:175-184. 10.1006/abio.1999.4461, 10660460.
29. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22:2021-2033. 10.1038/sj.onc.1206199, 12673207.
30. Darido C, Buchert M, Pannequin J, Bastide P, Zalzali H, Mantamadiotis T, et al. Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells. Cancer Res 2008, 68:4258-4268. 10.1158/0008-5472.CAN-07-5805, 18519685.
31. Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002, 21:2634-2640. 10.1038/sj.onc.1205351, 11965536.
32. Hsueh C, Chang YS, Tseng NM, Liao CT, Hsueh S, Chang JH, et al. Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma. Hum Pathol 2010, 41:944-950. 10.1016/j.humpath.2010.01.005, 20334898.
33. Usami Y, Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N, et al. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 2006, 37:569-577. 10.1016/j.humpath.2005.12.018, 16647955.
34. Sauer T, Pedersen MK, Ebeltoft K, Naess O. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 2005, 16:193-198. 10.1111/j.1365-2303.2005.00257.x, 16048505.
35. Tokes AM, Kulka J, Paku S, Mathe M, Paska C, Lodi C, et al. The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors. Pathol Res Pract 2005, 201:537-544. 10.1016/j.prp.2005.05.005, 16259105.
36. Rendon-Huerta E, Teresa F, Teresa GM, Xochitl GS, Georgina AF, Veronica ZZ, et al. Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas. J Gastrointest Cancer 2010, 41:52-59. 10.1007/s12029-009-9110-y, 19960275.
37. Tassi RA, Bignotti E, Falchetti M, Ravanini M, Calza S, Ravaggi A, et al. Claudin-7 expression in human epithelial ovarian cancer. Int J Gynecol Cancer 2008, 18:1262-1271. 10.1111/j.1525-1438.2008.01194.x, 18298564.
38. Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, Amasheh S, et al. Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 2010, 123:1913-1921. 10.1242/jcs.060665, 20460438.
39. Aung PP, Mitani Y, Sanada Y, Nakayama H, Matsusaki K, Yasui W. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch 2006, 448:428-434. 10.1007/s00428-005-0120-2, 16328347.
40. Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, et al. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 2007, 27:3729-3734.
41. Lioni M, Brafford P, Andl C, Rustgi A, El-Deiry W, Herlyn M, et al. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 2007, 170:709-721. 10.2353/ajpath.2007.060343, 1851859, 17255337.